Intravitreal ranibizumab in the treatment of subretinal neovascularization in a case of punctate inner choroidopathy

Abstract

AbstractPurpose To report a case of a subretinal neovascular membrane in a bilateral retinal lesions compatible with punctate inner choroidopathy (PIC) treated with intravitreal ranibizumab obtaining excellent results.Methods A 28‐year old woman suffering loss of visual acuity with her left eye, who presented an image suggestive of subretinal neovascular membrane in her left eye and bilateral retinal lesions compatible with punctate inner choroidopathy(PIC).Results In this situation it was decided to initiate treatment with intravitreal ranibizumab in OD,(monthly for a total of three injections). The visual acuity improved to 20/30 after 1 st injection. One month after the third injection, the BCVA was 20/20 and remained stable. During the year the patient has been followed in our department were no new symptoms or signs of activity.Conclusion The differential diagnosis must be made between PIC and the rest of “white dot syndromes" and the presumed ocular histoplasmosis syndrome (POHS). Angiogenic drugs may be a good alternative for the treatment of such diseases when they develop a subretinal neovascular membrane.